HDAC3 and cancer: In addition, as a novel non-invasive biomarker, extracellular vesicle expression of miR-193b-3p is upregulated in HeLa cancer cells and directly targets HDAC3 (Lin et al., 2018; Meng et al., 2018); it also attenuates neuroinflammation in early brain injury after aSAH in mice (Lai et al., 2020).